The article you requested is

Refractory Generalized Anxiety Disorder

J Clin Psychiatry 2009;70(suppl 2):32-38

Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.

Generalized anxiety disorder (GAD) has a lifetime prevalence in the US population of about 5.7%. Typically, GAD begins in early adulthood and tends to have a chronic and persistent course. The disorder frequently presents comorbidly with other conditions, and about 90% of patients with GAD have at least 1 comorbid lifetime psychiatric disorder. Patients with GAD tend to be high users of medical services; the disorder is associated with significant physical as well as psychological symptomatology and impacts health, family relationships, and employment. Pharmacologic and psychosocial treatments are available for GAD.​